 |
|
The Quality of Anticoagulation Management
Arch Intern Med. 2000;160:895-896.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
TREMENDOUS STRIDES have been made in the last 10 years in the prevention of ischemic stroke due to atrial fibrillation (AF). A series of randomized controlled trials have shown that warfarin therapy, targeting an international normalized ratio (INR) range of 2.0 to 3.0, can reduce the incidence of stroke by 64% to 87%,1-5 that warfarin is better than aspirin in select groups,6 and that patients with AF can be stratified into high- and low-risk categories to better define optimal therapy.7 Importantly, the benefit of anticoagulation therapy far outweighs the risk of major hemorrhage, the principal adverse effect of anticoagulants. But does it? The study by Samsa et al8 in this issue of the ARCHIVES suggests that there may be problems with the everyday management of oral anticoagulation that may lead to different outcomes than those experienced in the large randomized studies.
In the 1980s and 1990s, considerable effort was directed . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Better anticoagulation control improves survival after valve replacement
Butchart et al.
J. Thorac. Cardiovasc. Surg. 2002;123:715-723.
ABSTRACT
| FULL TEXT
A nurse led clinic and computer decision support software for anticoagulation decisions were as effective as a hospital clinic
Schmitt
Evid. Based Med. 2001;6:61-61.
FULL TEXT
Managing Oral Anticoagulant Therapy
Ansell et al.
Chest 2001;119:22S-38S.
FULL TEXT
Anticoagulation to prevent stroke in atrial fibrillation
Fitzmaurice et al.
BMJ 2000;321:1156-1156.
FULL TEXT
Additional Monitoring Tools to Improve the Quality of Anticoagulation Management
Kajubi
Arch Intern Med 2000;160:3006-3006.
FULL TEXT
|
